• N/A
    Market Cap
  • -75.00%
    1-Year Change
  • Biotechnology
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: N/A
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

No data found

No data found

Peers

Statistics

More
Day Range
$0.0002
$0.0002
$0.0002
1-Year Range
$0.0002
Latest Close$0.0002
Change
$0.00 (0.00%)
Volume1,000
Shares Outstanding6.7M
P/E (TTM)-1.50
Diluted EPS (TTM)-$0.30

Information as of 10/31/2025

Company Profile

EVOLUTIONARY GENOMICS, INC.
https://www.evolgen.com
N/A
Market Cap
-$1.9M
Net Income
Sector: Healthcare
Industry: Biotechnology
4220 Morning Star Drive, Castle Rock, CO, United States, 80108
303 513 3510

Evolutionary Genomics, Inc., together with its subsidiaries, engages in the research and identification of positively selected genes in humans, animals, and commercial crops. The company also develops Adapted Traits Platform, which is used to perform molecular evolution analysis to identify positively selected genes that may have an impact on traits of interest. It serves governmental organizations, non-profit foundations, and commercial entities. The company is based in Castle Rock, Colorado.

Key Executives

  • Walter Messier
  • Steve Warnecke
  • Virginia Orndorff

Current Ownership Distribution

  • Other4.3M (64.64%)
  • Insiders2.4M (35.36%)
  • Institutions0 (0.00%)
  • Mutual Funds0 (0.00%)